OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Scagliotti on the Benefits of EGFR Targeted Therapy

September 27th 2011

Dr. Giorgio Scagliotti from the University of Turin in Italy on EGFR Targeted Therapy Survival Benefits

Dr. Burtness on the Head and Neck Cancer Symposium

September 27th 2011

Dr. Barbara Burtness from Fox Chase Cancer Center Discusses the Upcoming Head and Neck Cancer Symposium

Dr. Ellis on Genome Forward Breast Cancer Treatment

September 26th 2011

Dr. Matthew Ellis from Washington University, St Louis, Discusses Genome Forward Breast Cancer Treatment

Dr. Yoneda Discusses Pulmonary Nodules

September 23rd 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center Discusses Pulmonary Nodules

Dr. McDonald on Approved Angiogenesis Inhibitors

September 22nd 2011

Dr. Donald McDonald from UCSF Comprehensive Cancer Center Explains Approved Angiogenesis Inhibitors

Dr. Wakelee on Explaining Adjuvant Therapy to Patients

September 21st 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Explaining Adjuvant Therapy to Patients

Dr. Tripathy Discusses Breast Carcinoma Heterogeneity

September 20th 2011

Dr. Debu Tripathy from Norris Comprehensive Cancer Center Discusses Breast Carcinoma Heterogeneity

Dr. Li Describes the Future of Lung Cancer Therapy

September 19th 2011

Dr. Tianhong Li from University of California Davis Cancer Center Describes the Future of Lung Cancer Therapy

Dr. Rugo on VEGF-A as an Avastin Response Predictor

September 16th 2011

Dr. Hope Rugo from UCSF Cancer Center on VEGF-A as an Avastin Response Predictor

Dr. Scagliotti Discusses EGFR Mutations in NSCLC

September 16th 2011

Dr. Giorgio Scagliotti from University of Turin Discusses EGFR Mutations in non-small cell lung cancer

Dr. Dixon on Letrozole With Pathway Inhibitors

September 15th 2011

Dr. J. Michael Dixon from University of Edinburgh on Letrozole Used in Combination With Pathway Inhibitors

Dr. O'Shaughnessy on the Future of TNBC Treatment

September 15th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Triple Negative Breast Cancer Treatment

Dr. Ellis on Hopeful ER+/HER2- Breast Cancer Paradigms

September 14th 2011

Dr. Matthew Ellis from Washington University on Anticipated ER-positive/HER2-negative Breast Cancer Paradigms

Dr. Wakelee on Adjuvant Therapy in Elderly Patients

September 14th 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Adjuvant Therapy in Elderly NSCLC Patients

Dr. Scagliotti on Tailored Treatment & Host Genomics

September 13th 2011

Dr. Giorgio Scagliotti from the University of Turin on Tailored Treatment and the Cancer Genome

Dr. Dixon on Systemic Advances in Breast Cancer

September 13th 2011

Dr. J. Michael Dixon from University of Edinburgh on Advances in Breast Cancer Systemic Therapy

Dr. McDonald on the Next Step for Angiogenesis Inhibitors

September 13th 2011

Dr. Donald McDonald from the UCSF Comprehensive Cancer Center on the Next Step for Angiogenesis Inhibitors

Dr. Yoneda Discusses Integrating the Pulmonologist

September 12th 2011

Dr.Ken Yoneda from UC Davis Cancer Center Discusses Integrating the Pulmonologist into Multidisciplinary Practice

Dr. Bradley Discusses Key Lung Cancer Topics

September 12th 2011

Dr. Jeffrey Bradley from Washington University School of Medicine Discusses Key Lung Cancer Topics

Dr. Tripathy Discusses Biomarker Use in Clinical Trials

September 12th 2011

Dr. Debu Tripathy from the USC Norris Comprehensive Cancer Center Discusses Biomarker Use in Clinical Trials